Cooperativity and induced oligomerization control the interaction of SARS-CoV-2 with its cellular receptor and patient-derived antibodies
Main Authors: | Asor, R, Olerinyova, A, Burnap, SA, Kushwah, MS, Hensen, M, Vasiljevic, S, Chang, L, Dejnirattisa, W, Supasa, P, Stuart, DI, Screaton, GR, Zitzmann, N, Benesch, JLP, Struwe, WB, Kukura, P |
---|---|
Format: | Conference item |
Language: | English |
Published: |
Cell Press
2024
|
Similar Items
-
Lifting the concentration limit of mass photometry by PEG nanopattering
by: Kratochvil, J, et al.
Published: (2024) -
Characterizing the Impact of Oligomerization on Redox Flow Cell Performance
by: Weiss, Trent A, et al.
Published: (2024) -
Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium
by: Nhu, LNT, et al.
Published: (2024) -
Investigation on the mechanism of amyloid beta peptides oligomerization and the process for its inhibition
by: Zhao, Li Na
Published: (2013) -
Defining proteoform-specific interactions for drug targeting in a native cell signalling environment
by: Lutomski, CA, et al.
Published: (2025)